StonvexLoading…
StonvexStonvexStonvexCore line items from RXO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.43B | $5.74B | $4.27B | $2.85B |
Operating Income | $-28.00M | $-79.00M | $-37.00M | $-30.00M |
Net Income | $-36.00M | $-100.00M | $-54.00M | $-40.00M |
EPS (Diluted) | $-0.21 | $-0.59 | $-0.32 | $-0.24 |
Total Assets | $3.27B | $3.28B | $3.20B | $3.20B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $21.00M | $17.00M | $25.00M | $18.00M |
Free Cash Flow OCF − CapEx | $-24.00M | $-8.00M | $1.00M | $-8.00M |
Shares Outstanding | 164.87M | 164.16M | 164.10M | 163.97M |